Specifically, the reduction in adiponectin levels associated with abdominal obesity contributes to heightened insulin resistance and liver inflammation, further exacerbating NAFLD [30]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.